NABP Drug Distributor Accreditation Supply Chain Inspection Overview Written-by: Deneen Fumich, RPh Effective January 1, 2022, NABP made major changes to the Drug Distributor Accreditation (DDA fka VAWD) process. Some of the major changes to note are to the policy and...
FDA Proposed Rules Review, Part 1 of 4: An Introduction Written-by: Sumeet Singh, CEO This article will review the FDA’s proposed rule concerning National Standards for Licensure of Wholesale Drug Distributors as well as the Executive Summary purpose of proposed rules...
FDA and NABP Temporarily Curtailing Onsite Inspections Due to COVID-19 In order to ensure the safety of its employees both FDA and the National Association of Boards of Pharmacy (NABP) have made temporary changes to their inspectional activities as they adjust and...
Emergency Use Authorization Policy Ending for EAU Medical Devices Written-by: Sumeet Singh, CEO FDA To Host Webinar to Establish Transition Framework for End to Temporary Emergency Use Authorization Policy and Enforcement Discretion for EUA Medical Devices EUAs and...
DSCSA Final Proposal Rules Submitted to OMB Is 2022 the year for FDA to release Proposed Rules for the National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers? History November 27, 2013 saw the passage of Title II of the...
